LeukoTrace
Increased Quality of Life
Our innovation not only strengthens the healthcare system but also enhances the overall quality of life for patients and their families.
1. Early Detection
-
Increased chance of successful treatment or cure
-
More effective treatment plan can be implemented
-
Have options of treating the cancer
2. Personalized Treatment
-
Improved precision in identifying problems
-
Encourages sense of responsibility for well-being
-
Sustainable health improvements
3. More Affordable
-
Prevents unnecessary diagnostic tests
-
Designed for areas with limited resources
-
Assist financially disadvantaged
4. Non-Invasive Procedures
-
Shorter recovery period
-
Minimal pain or permanent scarring from treatment
-
Lower risk of future complications from long period exposure
​5. Benefits of Screening Tests
-
Used to detect potential signs of leukemia before symptoms appear
-
Improve health awareness and encourage proactive approach to well-being
-
Less intensive treatment later
71%
of cancer patients are more likely to face financial hardship within 2 years of diagnosis
[22].
Diagnostic Tests
The costs of leukemia diagnosis amounted to $6,556.21 without insurance!
VS
-
Complete blood count
-
Flow cytometry
-
Bone marrow biopsy
-
Genetic testing
LeukoTrace
Improves Healthcare Delivery
Reduced Hospital Stays
Quick results enable faster treatment decisions, potentially shortening hospital stays.
Faster Results
Point of Care Testing (POCT) provides rapid turnaround times, often yielding results within minutes.
Flexibility and
Accessibility
POCT can be done in small clinics and remote areas, allowing patients to access testing without visiting large medical centers.